Cell line/Subline | HLA class I | HLA class II | ICAM-1 |
---|---|---|---|
Derived from primary lesion | |||
NPC039 | |||
Nontransduced | 99.9 (73.0) * | 0.4 | 99.7 (22.1) |
Transduced | 99.3 (231.8) | 40.1 (22.0) | 99.3 (61.1) |
NPC076 | |||
Nontransduced | 97.9 (96.8) | 0.1 | 93.2 (16.8) |
Transduced | 94.1 (147.3) | 28.4 (30.8) | 90.8 (44.7) |
NPC-BR | |||
Nontransduced | 95.8 (78.7) | 0.5 | 95.9 (25.4) |
Transduced | 97.9 (139.7) | 48.7 (36.2) | 96.7 (50.2) |
NPC039-2E2 § | |||
Nontransduced | 99.9 (138.8) | 0.1 | 86.9 (13.5) |
Transduced | 99.9 (179.5) | 72.4 (44.0) | 96.6 (30.5) |
NPC039-6A1 § | |||
Nontransduced | 89.5 (71.6) | 2.3 (8.2) | 79.1 (13.6) |
Transduced | 97.6 (283.0) | 48.8 (47.7) | 86.0 (27.3) |
NPC039-7B2 § | |||
Nontransduced | 99.6 (44.3) | 0.9 (6.8) | 90.7 (10.2) |
Transduced | 98.8 (88.7) | 39.5 (58.0) | 95.3 (23.9) |
Derived from bone marrow metastasis | |||
NPC-BM1 | |||
Nontransduced | 91.2 (55.3) | 26.2 (28.8) | 87.8 (26.9) |
Transduced | 96.8 (97.6) | 41.9 (28.2) | 91.7 (28.8) |
NPC-BM3 | |||
Nontransduced | 89.4 (78.2) | 18.6 (33.4) | 87.1 (19.6) |
Transduced | 93.1 (121.6) | 66.7 (50.5) | 93.8 (49.2) |